Fingerprint
Dive into the research topics of 'Clonal evolution of AML on novel FMS-like tyrosine kinase-3 (FLT3) inhibitor therapy with evolving actionable targets'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Clonal evolution of AML on novel FMS-like tyrosine kinase-3 (FLT3) inhibitor therapy with evolving actionable targets
Pashtoon M. Kasi, Mark R. Litzow, Mrinal M. Patnaik, Shahrukh K. Hashmi, Naseema Gangat
Research output: Contribution to journal › Article › peer-review
9
Scopus
citations